WFH Awards

The World Federation of Hemophilia (WFH) and its national member organizations (NMO) are powered by dedicated individuals who believe that together, a certain future can be brought to those living with a bleeding disorder around the world.

WFH VOLUNTEER AWARDS

The WFH Volunteer Awards were created to recognize the outstanding leadership provided by our volunteers who help further our vision of Treatment for All.

Nominations are now being accepted for the International Frank Schnabel Volunteer Award, the International Healthcare Volunteer Award, and the President’s Award.

For more information, please contact [email protected].

Call for nominations now open!

Do you know someone who has made an outstanding contribution to the local or global bleeding disorders community? If so, let your voice be heard: the WFH is now accepting nominations for the 2026 WFH Volunteer Awards. The deadline to submit a nomination is November 30th, 2025.

Winners will be announced during the WFH 2026 World Congress in Kuala Lumpur, Malaysia.

WFH 2024 World Congress awards

During the WFH 2024 World Congress, six WFH awards were bestowed—to individuals and one organization—recognizing their contributions to the global inherited bleeding disorders community.

Read the article to learn more about the winners.

The International Frank Schnabel Award was established in 2004, named in honour of WFH founder Frank Schnabel. It is given to an individual with hemophilia, an inherited bleeding disorder, or to a family member, who has contributed significantly in furthering the mission and goals of the WFH.

The award is given every two years at the WFH World Congress.

We invite you to nominate an individual with hemophilia or another inherited bleeding disorder, or a family member who has contributed significantly in furthering the mission and goals of the WFH. Nominees must meet the criteria below in order to be considered.

Criteria:

  • A minimum of eight (8) years’ involvement in the work of WFH as a volunteer. Having impacted through leadership, actions, and behavior, not only the individual’s country of origin but also the region, other regions or having a global impact
  • Involvement in one or several areas such as WFH committees and programs on blood safety, communications, healthcare development, fundraising, congress, or WFH national member organizations

Not Eligible:

  • Current WFH Board of Directors, individuals running for the 2026 board elections and WFH Staff are not eligible for nomination
  • Current members of the Medical Advisory Board (MAB)

Established in 2004, this award honours a healthcare professional who has contributed significantly to furthering the mission and goals of the WFH in a volunteer role. Candidates for this award include doctors, nurses, physiotherapists, psychologists, social workers, dentists, and other health professionals, who provide care and treatment to people with inherited bleeding disorders.

The award is given every two years at the WFH World Congress.

We invite you to nominate a healthcare professional who has contributed significantly in furthering the mission and goals of the WFH. Nominees must meet the criteria below in order to be considered.

Criteria:

  • A number of years’ involvement in the work of WFH
  • Involvement in one or several areas such as WFH committees and programs on blood safety, communications, healthcare development, fundraising, congress, or WFH national member organizations
  • Nominations for this award are for an individual’s volunteer role with WFH and not for their professional role as healthcare provider or researcher

Not Eligible:

  • Current WFH Board of Directors, individuals running for the 2026 board elections and WFH Staff are not eligible for nomination.
  • Members of the Medical Advisory Board (MAB)

Established in 2018, the WFH President’s Award recognizes an individual or organization that has served their local community and made a substantial impact in the bleeding disorders community within their country. The award is given every two years at the WFH World Congress.

We invite you to nominate an individual (over 18) / organization, with a minimum of five years of active leadership in their local bleeding disorders community, who has made an impact nationwide and contributed significantly to advancing the mission and goals of the WFH.

Beginning in 2024, a new sub-category has been added to the President’s Award to recognize individuals and organizations working to increase recognition, visibility, and improve diagnosis and/or access to care for women and girls with bleeding disorders (WGBD).

Nominations for the President’s Award may be submitted for any of the following categories. Up to three awards will be presented:

  1. Individual or Organizations such as an NMO leader, chapter leader, youth leader, local lay individual and/or leader of any other group, serving their local bleeding disorders community and/or country.
  2. Healthcare Professional making an impact in their local bleeding disorders community and/or country.
  3. Advocate for Women and Girls with Bleeding Disorders: An individual / organization making an impact towards improving access to care and/or diagnosis for Women & Girls with bleeding disorders.

Nominees must meet the criteria below in order to be considered.

Criteria for Individual/Organizations or Healthcare Professionals

  • Demonstrate a minimum of five years of active leadership in the bleeding disorders community within their own country
  • Demonstrate a positive relationship with a WFH national member organization (NMO)
  • Development of a project/initiative that has resulted with making a nationwide impact in the bleeding disorder community due to their leadership
  • Winners will be selected from the finalists chosen from all the nominations received and could either be an NMO leader, chapter leader, youth leader, local lay or medical volunteer, and/or chapter/NMO/youth group, or other organization.

Not Eligible:

  • Volunteer leaders serving on international boards or WFH committees (such as the WFH and WFH USA Board of Directors and WFH Medical Advisory Board
  • Individuals/organizations not associated with a WFH NMO.
  • Individuals running for the 2026 board elections and WFH Staff are not eligible for nomination.

Presidents’ Award: Women and Girls with Bleeding Disorders Category

This category of the Presidents’ Award recognizes an individual or an organization who has demonstrated consistent dedication and service towards advancing the recognition, diagnosis, and equitable access to care of Women and Girls with Bleeding Disorders (WGBD). The individual or organization nominated should be an advocate for WGBD and have made significant impact in reshaping perceptions surrounding bleeding disorders among women and girls. Their efforts should have significantly increased the recognition and visibility of WGBD within the broader bleeding disorders community.

Criteria

  • Candidate is an individual or organization that has been involved in programs or initiatives with focus on improving the capacity of NMOs and HCPs to diagnose and provide specialized care to WGBD.
  • Candidate is an individual or organization that has been an avid advocate for WGBD and has made significant impact in changing the mindsets that women are solely carriers.
  • Candidate is an individual or organization that has shown dedication towards fostering collaboration between different stakeholders (NMOs, HCPs and government institutions as well as civil society) to achieve equitable access to diagnosis and care for WGBD.
  • Candidate is an individual or organization that has demonstrated commitment to raising awareness in their community about WGBD’s issues.

Not Eligible

  • Volunteer leaders serving on boards or WFH committees (such as the WFH and WFH USA Board of Directors and WFH Medical Advisory Board)
  • Individuals or organizations not associated with a WFH NMO
  • Individuals running for the 2026 board elections and WFH Staff are not eligible for nomination.

This Award was established in 2006 and is given to an individual in recognition of a body of work over a period of time. Recipients have contributed to furthering the mission and goals of the World Federation of Hemophilia in a particular region, country or professional area, throughout their career and for a significant part of their lives.

This Award is given, when merited, at the bi-annual World Congress or may be given, when appropriate, during formal meetings with WFH leadership.

Established in 2010, this Award is given to an individual or an organization that has demonstrated outstanding service to the World Federation of Hemophilia (WFH) and to furthering the mission of the WFH. The recipient is a role model and will have demonstrated leadership, commitment, and active dedication to serving the bleeding disorders community. The recipient’s efforts have resulted in a measurable difference in the care of people with bleeding disorders.

This Award is given, when merited, at the bi-annual World Congress or may be given, when appropriate, during formal meetings with WFH leadership.

WFH PROGRAM AND RESEARCH AWARDS

The Twins of the Year Awards are given out annually to hemophilia treatment centre twins, and hemophilia organization and youth group twins that best showcase the philosophy of the Twinning Program.

Criteria

  • Demonstrated high level of commitment to the partnership
  • Demonstrated teamwork on all endeavours
  • Achieved objectives that were set for the year
  • Exhibited excellent communication between partners
  • Sustained level of activity
  • Executed complex activities
  • Provided documentation in a complete and timely manner
  • Are not previous Twins of the Year Award winners

Selection

Selection is made by the Hemophilia Treatment Centre (HTC) Twinning and Hemophilia Organization Twinning (HOT) committees. The plaques are presented to the recipients during the WFH World Congress, which takes place every two years.


2023 Twins of the Year

HTCHOT
Semarang (Indonesia) – Utrecht (Netherlands)Rwanda – Pays de la Loire (France)

The Pietrogrande Prize was created in 2005 to recognize a healthcare professional who has contributed significantly in furthering the mission and goals of the Musculoskeletal Committee of the WFH.

The prize honours Dr. Vincenzo Pietrogrande, a leading orthopedic surgeon and director of the Institute of Clinical Orthopedics at the University of Milan, Italy. Dr. Pietrogrande was the first chair of the group that eventually became the Musculoskeletal Committee.

The WFH presents the prize every two years at the WFH Musculoskeletal Congress.

This award was established in 1998 to honour the memory of Professor Henri Horoszowski, former chairperson of the Musculoskeletal Committee, to encourage musculoskeletal specialists to become involved in hemophilia care.

Presenters of any free papers selected for inclusion in each Musculoskeletal Congress and each musculoskeletal program of the WFH World Congress are eligible for the award, with two exceptions:

  • Current or past members of the Musculoskeletal Committee
  • Previous winners of the award

Criteria for the award include scientific methodology, originality, relevance, and quality of the presentation as determined by a panel of judges appointed by the Musculoskeletal Executive Committee.

For more information, contact Rohini Dange [email protected].

WFH PARTNER AWARDS

Established in 2012 by the World Federation of Hemophilia (WFH) and Wiley, the Christine Lee Young Researcher Award (formerly the Christine Lee Haemophilia Journal Award) is given in recognition to a top young researcher (graduate student or postdoctoral fellow) who is the primary author and presenter of a highly rated submitted abstract in any discipline involving hemophilia or other related bleeding disorders.

The selection committee, including the Haemophilia Journal’s editors and WFH representatives on the Haemophilia Editorial Board, will choose the best presented abstract at the WFH World Congress.

A prize of $3,000 for the best free paper presentation and a prize of $1,000 for the best poster presentation, along with a three-year online personal subscription to Haemophilia is provided for both awards.

The young researcher must be under the age of 40 at the time the article is submitted. If there are multiple authors, the lead author and presenter must be under the age of 40 at the time the article is submitted.

With generous unrestricted grants from the pharmaceutical industry, the Swedish Hemophilia Society launched the Arosenius Fund in 1996 in the name of Ivar Arosenius, a famous Swedish artist who lived with a bleeding disorder.

The fund supports travel to conferences and workshops, allowing recipients to reach the national and international research community.

Did you know?

The WFH closely monitors product safety, supply, and access; issues advisories related to treatment safety and supply; and monitors the development and regulatory status of new and novel treatments.

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.

WFH President's Award - Recipients

International Frank Schnabel Volunteer Award - Recipients

Previous years

2012Martha Patricia Monteros Rincon
Mexico
2010Antonia Luque de Garrido
Venezuela
2008Jean Michel Bouchez
France
2006Yuri Zhulyov
Russia
2004Ashok Verma
India

International Lifetime Achievement Award - Recipients

Previous years

2012Christine Lee
United Kingdom
2006Dr. Bruce Evatt
United States

The Arosenius Fund (Swedish Hemophilia Society)

2022 Peter Lenting
2020 Steve Pipe
2018 Amy Shapiro
2017 Amy Shapiro
2016 Dr. Midori Shima

Christine Lee Young Researcher Award

2025 Ilenia Calcaterra
Italy
Best oral presentation:
Intensive FVIII replacement in haemophilia patients with hypertrophic synovium: a randomized study
2024 Geneviève McCluskey
France
Best oral presentation:
Fitusiran displays efficient pro-hemostatic activity in a mouse model of inducible factor X-deficiency
2024 Rodrigo Núñez Cortés
Chile
Best poster presentation:
Effects of resistance training on muscle strength in adults with haemophilia: a systematic review and meta-analysis
2023 Gabriela Yamaguti-Hayakawa
Brazil
Best free paper presentation:
Musculoskeletal Health After Gene Therapy For Hemophilia A: A Three-Year Follow-Up Longitudinal Study
2022 Merel A. Timmer
Netherlands
Best free paper presentation:
Feasibility and proof of concept of e-Exercise haemophilic arthropathy
2020 Dr. Ozlem Turan
UK
2017 Dr. Heike Singer
University Hospital Bonn
Bonn, Germany
Best free paper presentation:
Detection and localization of intracellular FVIII in IPS derived endothelial cells from three Hemophilia A (HA)-patients with null mutations
2017 Dr. Badle Saket
Clinical Research Fellow Barts and the London School of Medicine and Dentistry
The Royal London Hospital Haemophilia Centre London, United Kingdom
Best poster presentation:
Pharmacokinetic intervention to optimise FVIII prophylaxis: UKPK trial interim analysis
2014 Laurens Nieuwenhuizen
Netherlands (2014 recipient)

Susanna Lovdahl
Sweden (2013 recipient)

International Award for Outstanding Service - Recipients

International Healthcare Volunteer Award - Recipients

Previous years

2012 Piet de Kleijn
The Netherlands
2010 Dr. Mammen Chandy
India
2008 Dr. Man-Chiu Poon
Canada
2006 Dr. Norma de Bosch
Venezuela
2004 Dr. Parttraporn Insarangkura
Thailand

Dr. Carol K. Kasper
United States

Twins of the Year Awards

2022 Amman (Jordan) – Dublin (Ireland)
2021 Addis Ababa (Ethiopia) – Minneapolis (U.S.A) and
Tehran (Iran) – Milan (Italy)
2020 Aluva (India) – Newcastle (UK)
2019 Yogyakarta / Solo (Indonesia) – Utrecht (Netherlands)
2018 Abidjan (Ivory Coast) – Brussels (Belgium)
2017 Santa Cruz de la Sierra (Bolivia) – Buenos Aires (Argentina)
2016 Kampala (Uganda) – London (UK)
2015 Varna (Bulgaria) – Bonn (Germany)
2014 Arequipa (Peru) – Los Angeles (USA)
2013 Davangere (India) – Liverpool (UK)
Ludhiana (India) – Detroit (USA)
2012 Hanoi (Vietnam) – Melbourne (Australia)
2011 Manado (Indonesia) – Utrecht (Netherlands)
2010 Delhi (India) – Winnipeg (Canada)
Yaoundé (Cameroon) – Geneva (Switzerland)
2009 Chisinau (Moldova) – Warsaw (Poland)
Colombo (Sri Lanka) – Vellore (India)
2008 Gaborone (Botswana) – Philadelphia (USA)
2007 Vientiane (Laos) – Brest (France)
Damascus (Syria) – Montpellier (France)
2006 Lima (Peru) – Fort Worth (USA)
2005 Yerevan (Armenia) – Minneapolis (USA)
Casablanca (Morocco) – Caen (France)
2004 Beirut (Lebanon) – Geneva (Switzerland)
Santo Domingo (Dominican Republic) – Caracas (Venezuela)
2003 Cairo (Egypt) – Knoxville (USA)
2002 Moscow (Russia) – Liverpool (UK)
Panama – Valencia (Spain)
2001 Bangalore (India) – St. Louis (USA)
2000 Pune (India) – Bradford (UK)
1999 Montevideo (Uruguay) – Buenos Aires (Argentina)
Tianjin (China) – Calgary (Canada)
1998 Plovdiv (Bulgaria) – Bonn (Germany)
1997 Bogota (Colombia) – Los Angeles (USA)
Tartu (Estonia) – Stockholm (Sweden)
1996 Timisoara (Romania) – Munich (Germany)
Riga (Latvia) – Munster (Germany)
1995 Klaipeda (Lithuania) – Malmo (Sweden)
1994 Bratislava (Slovakia) – Tel Hashomer (Israel)

Pietrogrande Prize

2025Greig Blamey
Canada
2023Nicholas Goddard
United Kingdom
2021Axel Seuser
Germany
2019Dr. Adolfo Llinás
Colombia
2017Pamela Hilliard
Canada
2015Kathy Mulder
Canada
2013James Luck
United States
2012Piet de Kleijn
The Netherlands
2011Dr. Lily Heijnen
The Netherlands
2010Dr. Horacio Caviglia
Argentina
2009Jerome D. Wiedel
United States
2008Dr. Federico Fernández-Palazzi
Venezuela
2007Michael Heim
Israel
2006Brenda Buzzard
United Kingdom
2005Dr. Marvin Gilbert
United States

Henri Horoszowski Award

2025 Shubhranshu S. Mohanty
India
Haemophilic pseudotumour – New improvised classification system and its outcome in 168 cases at a Tertiary care centre
2021 Baolai Hua
China
The effects of intra-articular injection of TNF-alpha Antagonists in treatment of haemophilic synovitis
2019 Maarten Eerdekens
Belgium
Association between multi-segment foot kinetics and blood induced joint damage in adult patients with hemophilic ankle arthropathy
2017 Fabio Souza
Brazil
Decrease in joint inflammation, swelling and pain after a swimming protocol in animal model of experimental-induced hemarthrosis
2015 SM Javd Mortazavi
Iran
Bilateral total knee arthroplasty in patients with hemophilia: A safe and cost-effective procedure
2013 Lize F.D. van Vulpen
United States
A fusion protein of IL4 and IL10, is equally effective in protecting cartilage from blood-induced damage compared to the individual components
2012 Horacio Caviglia
Argentina
Pseudotumor Surgery in Haemophilia A patients: Comparitive results between inhibitor and non-inhibitor patients
2011 Nick Goddard
United Kingdom and
Monique van Meegeren
The Netherlands
Early onset administration of IL-4 and IL-10 prevents blood-induced cartilage damage in vitro
2010 Lydia Abad-Franch
Spain
Influence of an Aquatic Training Protocol on the Reduced Risk of Cardiovascular Morbidity and Mortality in a Hemophiliac
2009 Sebastien Lobet
Belgium
Impact of Hemophilia Ankle Arthropathy on Gait Disability: Analysis of Energetic and Mechanical Variables
2008 Jose Alberto Tlacuilo-Parra
Mexico
Bone Turnover Markers and Bone Mineral Density in Children with Hemophilia
2007 Natalie Jansen
The Netherlands
Protective Abilities of Interleukin-10 in Blood-induced Cartilage Damage
2006 Axel Seuser and E. Kusch
Germany
Multi-Center Study of Orthopedic Outcome of the Lower Extremities in 249 Children with Hemophilia
2005 Frank van Genderen, Nico van Meeteren, Lily Heijnen, Piet de Kleijn, Marijke van den Berg, Paul Helders
The Netherlands
The Hemophilia Activities List: Final development and validation of a hemophilic-specific self-assessment questionnaire on functional abilities
2004 Goris Roosendaal, Zalima N Jahangier, Kim MG Jacobs, Johannes WJ Bijlsma, Floris PJG Lafeber
The Netherlands
Radiosynoviorthesis using YTTRIUM-90 results in adverse direct effects on cartilage: a human in vitro study
2003 Axel Seuser, Thomas Wallny, Günter Schumpe, Elmar Trunz, Hans-Hermann Brackman
Germany
How to advise young haemophiliacs to find the right sport? A new and safe algorithm
2002 James Luck, Jr. and Mauricio Silva
United States
Long-Term Review of Total Knee Arthroplasty
2001 Federico Fernández-Palazzi
Venezuela
Oxytetracycline Chlorohydrate: A new material for chemical synovial orthoses
2000 Horacio Caviglia
Argentina
Pseudotumours
1999 William J. Ribbans and J.L. Hicks
United Kingdom
Communication and Co-operation for the New Millennium – The Future of the Musculoskeletal Committee in the 21st Century
1998 Adolfo Llinas, Mauricio Silva, Monica Duarte, Gonzalo Ucros, Graciela Perini, Angela Maria Cerquera, Andres Forero
Colombia
Chromic phosphate synoviorthesis without age restriction should be the first treatment option for chronic active hemophilic synovitis